脳腫瘍治療薬：2030年までの世界市場

Report Highlights

The report provides an analysis of brain tumor therapeutics and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented by therapy type, patient age, end user, and region. The report covers regulatory scenarios, drivers, restraints, opportunities, and the market share for key companies.

Report Includes

• An overview of the current and future global market potential for brain tumor therapeutics
• Analyses of the global market trends, with historical market revenue data from 2022 to 2024, estimates for 2025, and projections of CAGRs through 2030
• Estimates of the market size and revenue growth prospects, along with a corresponding market share analysis by therapy type, patient age group, end user and region
• Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impacts of macroeconomic variables
• Impact analysis of U.S. tariff laws, as well as use cases of AI adoption on the market
• Insights derived from Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
• A relevant patent analysis, featuring key granted and published patents
• Analysis of the industry structure, including companies’ market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
• Profiles of the leading companies

Report Scope

This report provides detailed information on brain tumor therapeutics. It analyzes the market trends for brain tumor therapeutics with data from 2024, estimates from 2025, projections of compound annual growth rates through 2030 (forecast period 2025–2030) and regional markets for brain tumor therapeutics. This report highlights brain tumor therapeutics’ current and future market potential and providess a detailed competitive environment analysis. The report covers regulatory scenarios, drivers, restraints and opportunities. It also covers market projections for 2030 and the market share for key companies.

This brain tumor therapeutics market is segmented by therapy type into chemotherapy, targeted therapy and immunotherapy. The patient age segment is segmented into adults and pediatrics. The end user segment is segmented into hospitals and home care settings.

The market has been segmented into the following major regions: North America, Europe, Asia-Pacific, the Middle East and Africa and South America. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia and India. For market estimates, 2024 is used as the base year, with forecasts for 2025 and a forecast value for 2030.

The report aims to:

• Analyze types of brain tumors and related therapeutics.
• Analyze global market size and segmentation.
• Understand market constraints and drivers.
• Provide detailed market forecasts for 2030.
• Assess market shares, competitiveness and industry structure.
• Identify potential long-term impacts on the brain tumor therapeutics market.

Table of Contents

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Macroeconomic Factors Analysis
Impact of U.S. Tariffs on the Pharmaceutical Industry
Healthcare Expenditure
Impact of Global Economic Growth on the Pharma Sector
Porter’s Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Incidence of Brain Tumor Cases
Increasing R&D Spending by Market Players
Rise in Government Funding and Pharmaceutical R&D Spending
Market Restraints
Inadequate Treatment Options for Brain Tumors
High Cost of Brain Cancer Drugs
Low Screening of Brain Tumors
Market Opportunities
Increasing Availability of Biosimilars and Generics
Research Collaborations
Chapter 4 Regulatory Landscape
Regulatory Dynamics
U.S.
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Pipeline Analysis
Emerging Trends/Technologies
Artificial Intelligence
Biomarkers
Pipeline Analysis
Key Takeaways
Patent Analysis
Key Takeaways
Chapter 6 Market Segment Analysis
Segmentation Breakdown
Global Brain Tumor Therapeutics Market, by Therapy Type
Key Takeaways
Chemotherapy
Targeted Therapy
Immunotherapy
Global Brain Tumor Therapeutics Market, by Patient Age
Key Takeaways
Adults
Pediatric
Global Brain Tumor Therapeutics Market, by End User
Key Takeaways
Hospitals
Home Care
Geographic Breakdown
Global Brain Tumor Therapeutics Market, by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Company Share Analysis
Chapter 8 Sustainability in Brain Tumor Therapeutics: ESG Perspective
Introduction to ESG
Sustainability in the Brain Tumor Therapeutics Market
ESG Perspective
Environmental Impact
Social Impact
Governance Impact
ESG Risk Ratings
Conclusion
Chapter 9 Appendix
Methodology
Abbreviations
Sources
Company Profiles
AMGEN INC.
AMNEAL PHARMACEUTICALS LLC.
BAXTER
BAYER AG
F. HOFFMANN-LA ROCHE LTD.
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
SERVIER LABORATORIES
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Emerging Players/Market Disruptors

List of Tables

List of Tables
Summary Table : Global Market for Brain Tumor Therapeutics, by Region, Through 2030
Table 1 : Global Health Expenditure, by Selected Country, 2021–2023
Table 2 : Available Biosimilars of Avastin (bevacizumab) in the Market
Table 3 : List of Selected Clinical Trials Studies on Brain Tumor Therapeutics, 2025
Table 4 : List of Selected Patents Related to Brain Tumor Therapeutics, 2024–2025
Table 5 : Global Market for Brain Tumor Therapeutics, by Therapy Type, Through 2030
Table 6 : Global Market for Chemotherapy in Brain Tumor Therapeutics, by Region, Through 2030
Table 7 : Global Market for Targeted Therapy in Brain Tumor Therapeutics, by Region, Through 2030
Table 8 : Global Market for Immunotherapy in Brain Tumor Therapeutics, by Region, Through 2030
Table 9 : Global Market for Brain Tumor Therapeutics, by Patient Age, Through 2030
Table 10 : Global Market for Adult Brain Tumor Therapeutics, by Region, Through 2030
Table 11 : Global Market for Pediatric Brain Tumor Therapeutics, by Region, Through 2030
Table 12 : Global Market for Brain Tumor Therapeutics, by End User, Through 2030
Table 13 : Global Market for Brain Tumor Therapeutics for Hospitals, by Region, Through 2030
Table 14 : Global Market for Brain Tumor Therapeutics for Home Care Settings, by Region, Through 2030
Table 15 : Global Market for Brain Tumor Therapeutics, by Region, Through 2030
Table 16 : North American Market for Brain Tumor Therapeutics, by Therapy Type, Through 2030
Table 17 : North American Market for Brain Tumor Therapeutics, by Patient Age, Through 2030
Table 18 : North American Market for Brain Tumor Therapeutics, by End User, Through 2030
Table 19 : North American Market for Brain Tumor Therapeutics, by Country, Through 2030
Table 20 : European Market for Brain Tumor Therapeutics, by Therapy Type, Through 2030
Table 21 : European Brain Tumor Therapeutics Market, by Patient Age, Through 2030
Table 22 : European Market for Brain Tumor Therapeutics, by End User, Through 2030
Table 23 : European Market for Brain Tumor Therapeutics, by Country, Through 2030
Table 24 : Asia-Pacific Market for Brain Tumor Therapeutics, by Therapy Type, Through 2030
Table 25 : Asia-Pacific Market for Brain Tumor Therapeutics, by Patient Age, Through 2030
Table 26 : Asia-Pacific Market for Brain Tumor Therapeutics, by End User, Through 2030
Table 27 : Asia-Pacific Market for Brain Tumor Therapeutics, by Country, Through 2030
Table 28 : South American Market for Brain Tumor Therapeutics, by Therapy Type, Through 2030
Table 29 : South American Market for Brain Tumor Therapeutics, by Patient Age, Through 2030
Table 30 : South American Market for Brain Tumor Therapeutics, by End User, Through 2030
Table 31 : South American Market for Brain Tumor Therapeutics, by Country, Through 2030
Table 32 : MEA Market for Brain Tumor Therapeutics, by Therapy Type, Through 2030
Table 33 : MEA Market for Brain Tumor Therapeutics, by Patient Age, Through 2030
Table 34 : MEA Market for Brain Tumor Therapeutics, by End User, Through 2030
Table 35 : MEA Market for Brain Tumor Therapeutics, by Sub-region, Through 2030
Table 36 : Key Focus Areas in ESG Metrics
Table 37 : ESG Rankings for Leading Companies in Brain Tumor Therapeutics Market, 2025*
Table 38 : Abbreviations Used in this Report
Table 39 : Information Sources for this Report
Table 40 : Amgen Inc.: Company Snapshot
Table 41 : Amgen Inc.: Financial Performance, FY 2023 and 2024
Table 42 : Amgen Inc.: Product Portfolio
Table 43 : Amgen Inc.: News/Key Developments, 2022 and 2023
Table 44 : Amneal Pharmaceuticals LLC.: Company Snapshot
Table 45 : Amneal Pharmaceuticals LLC.: Financial Performance, FY 2023 and 2024
Table 46 : Amneal Pharmaceuticals LLC.: Product Portfolio
Table 47 : Amneal Pharmaceuticals LLC.: News/Key Developments, 2022
Table 48 : Baxter: Company Snapshot
Table 49 : Baxter: Financial Performance, FY 2023 and 2024
Table 50 : Baxter: Product Portfolio
Table 51 : Baxter: News/Key Developments, 2024
Table 52 : Bayer AG: Company Snapshot
Table 53 : Bayer AG: Financial Performance, FY 2023 and 2024
Table 54 : Bayer AG: Product Portfolio
Table 55 : Bayer AG: News/Key Developments, 2025
Table 56 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 57 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 58 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 59 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024
Table 60 : Merck & Co. Inc.: Company Snapshot
Table 61 : Merck & Co. Inc.: Financial Performance, FY 2023 and 2024
Table 62 : Merck & Co. Inc.: Product Portfolio
Table 63 : Merck & Co. Inc.: News/Key Developments, 2024
Table 64 : Novartis AG: Company Snapshot
Table 65 : Novartis AG: Financial Performance, FY 2023 and 2024
Table 66 : Novartis AG: Product Portfolio
Table 67 : Novartis AG: News/Key Developments, 2023
Table 68 : Pfizer Inc.: Company Snapshot
Table 69 : Pfizer Inc.: Financial Performance, FY 2023 and 2024
Table 70 : Pfizer Inc.: Product Portfolio
Table 71 : Servier Laboratories: Company Snapshot
Table 72 : Servier Laboratories: Financial Performance, FY 2023 and 2024
Table 73 : Servier Laboratories: Product Portfolio
Table 74 : Servier Laboratories: News/Key Developments, 2023 and 2024
Table 75 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 76 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2023 and 2024
Table 77 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 78 : Few Emerging Players in the Brain Tumor Therapeutics Market

List of Figures

List of Figures
Summary Figure : Global Market Shares of Brain Tumor Therapeutics, by Region, 2024
Figure 1 : Porter’s Five Forces Analysis of the Brain Tumor Therapeutics Market
Figure 2 : Market Dynamics of Brain Tumor Therapeutics
Figure 3 : Leading Pharmaceutical Companies’ R&D Expenditure, by Function, 2022
Figure 4 : U.S. National Cancer Institute Research Funding, 2012–2019
Figure 5 : Global Pharmaceutical R&D Spending and Growth, 2020–2026
Figure 6 : Global Market Shares of Brain Tumor Therapeutics, by Therapy Type, 2024
Figure 7 : Global Market Shares of Chemotherapy in Brain Tumor Therapeutics, by Region, 2024
Figure 8 : Global Market Shares of Targeted Therapy in Brain Tumor Therapeutics, by Region, 2024
Figure 9 : Global Market Shares of Immunotherapy in Brain Tumor Therapeutics, by Region, 2024
Figure 10 : Global Market Shares of Brain Tumor Therapeutics, by Patient Age, 2024
Figure 11 : Global Market Shares of Adult Brain Tumor Therapeutics, by Region, 2024
Figure 12 : Global Market Shares of Pediatric Brain Tumor Therapeutics, by Region, 2024
Figure 13 : Global Market Shares of Brain Tumor Therapeutics, by End User, 2024
Figure 14 : Global Market Shares of Brain Tumor Therapeutics for Hospitals, by Region, 2024
Figure 15 : Global Market Shares of Brain Tumor Therapeutics for Home Care Settings, by Region, 2024
Figure 16 : Global Market Shares of Brain Tumor Therapeutics, by Region, 2024
Figure 17 : North American Market Shares of Brain Tumor Therapeutics, by Therapy Type, 2024
Figure 18 : North American Market Shares of Brain Tumor Therapeutics, by Patient Age, 2024
Figure 19 : North American Market Shares of Brain Tumor Therapeutics, by End User, 2024
Figure 20 : North American Market Shares of Brain Tumor Therapeutics, by Country, 2024
Figure 21 : European Market Shares of Brain Tumor Therapeutics, by Therapy Type, 2024
Figure 22 : European Market Shares of Brain Tumor Therapeutics, by Patient Age, 2024
Figure 23 : European Market Shares of Brain Tumor Therapeutics, by End User, 2024
Figure 24 : European Market Shares of Brain Tumor Therapeutics, by Country, 2024
Figure 25 : Asia-Pacific Market Shares of Brain Tumor Therapeutics, by Therapy Type, 2024
Figure 26 : Asia-Pacific Market Shares of Brain Tumor Therapeutics, by Patient Age, 2024
Figure 27 : Asia-Pacific Market Shares of Brain Tumor Therapeutics, by End User, 2024
Figure 28 : Asia-Pacific Market Shares of Brain Tumor Therapeutics, by Country, 2024
Figure 29 : South American Market Shares of Brain Tumor Therapeutics, by Therapy Type, 2024
Figure 30 : South American Market Shares of Brain Tumor Therapeutics, by Patient Age, 2024
Figure 31 : South American Market Shares of Brain Tumor Therapeutics, by End User, 2024
Figure 32 : South American Market Shares of Brain Tumor Therapeutics, by Country, 2024
Figure 33 : MEA Market Shares of Brain Tumor Therapeutics, by Therapy Type, 2024
Figure 34 : MEA Market Shares of Brain Tumor Therapeutics, by Patient Age, 2024
Figure 35 : MEA Market Shares of Brain Tumor Therapeutics, by End User, 2024
Figure 36 : MEA Market Shares of Brain Tumor Therapeutics, by Sub-region, 2024
Figure 37 : Global Market Shares of Brain Tumor Therapeutics, by Company, 2024
Figure 38 : Pillars of ESG
Figure 39 : Advantages of ESG for Companies
Figure 40 : Amgen Inc.: Revenue Share, by Business Unit, FY 2024
Figure 41 : Amgen Inc.: Revenue Share, by Country/Region, FY 2024
Figure 42 : Amneal Pharmaceuticals LLC.: Revenue Share, by Business Unit, FY 2024
Figure 43 : Baxter: Revenue Share, by Business Unit, FY 2024
Figure 44 : Baxter: Revenue Share, by Country/Region, FY 2024
Figure 45 : Bayer AG: Revenue Share, by Business Unit, FY 2024
Figure 46 : Bayer AG: Revenue Share, by Country/Region, FY 2024
Figure 47 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
Figure 48 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
Figure 49 : Merck & Co. Inc.: Revenue Share, by Business Unit, FY 2024
Figure 50 : Merck & Co. Inc.: Revenue Share, by Country/Region, FY 2024
Figure 51 : Novartis AG: Revenue Share, by Business Unit, FY 2024
Figure 52 : Novartis AG: Revenue Share, by Country/Region, FY 2024
Figure 53 : Pfizer Inc.: Revenue Share, by Business Unit, FY 2024
Figure 54 : Pfizer Inc.: Revenue Share, by Country/Region, FY 2024
Figure 55 : Servier Laboratories: Revenue Share, by Business Unit, FY 2024
Figure 56 : Servier Laboratories: Revenue Share, by Region, FY 2024
Figure 57 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Country/Region, FY 2024

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07
• 世界の電気アーク炉市場 2025-11-07

BCC Research  出版レポート一覧